A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy.
Saved in:
| Title: | A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy. |
|---|---|
| Authors: | Patel KR; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Rowe LS; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Schott E; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Cooley-Zgela T; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Ning H; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Turkbey B; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Choyke P; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Lindenberg L; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Mena E; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Pinto PA; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Zhang Q; Division of Cancer Treatment and Diagnosis: Biometric Research Program, National Cancer Institute, National Institutes of Health, Rockville, Maryland., Shih J; Division of Cancer Treatment and Diagnosis: Biometric Research Program, National Cancer Institute, National Institutes of Health, Rockville, Maryland., Salerno KE; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Citrin DE; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. |
| Source: | Advances in radiation oncology [Adv Radiat Oncol] 2022 Jul 15; Vol. 7 (6), pp. 101024. Date of Electronic Publication: 2022 Jul 15 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101677247 Publication Model: eCollection Cited Medium: Print ISSN: 2452-1094 (Print) Linking ISSN: 24521094 NLM ISO Abbreviation: Adv Radiat Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36420197 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Patel+KR%22">Patel KR</searchLink>; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Rowe+LS%22">Rowe LS</searchLink>; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Schott+E%22">Schott E</searchLink>; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Cooley-Zgela+T%22">Cooley-Zgela T</searchLink>; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Ning+H%22">Ning H</searchLink>; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Turkbey+B%22">Turkbey B</searchLink>; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Choyke+P%22">Choyke P</searchLink>; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Lindenberg+L%22">Lindenberg L</searchLink>; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Mena+E%22">Mena E</searchLink>; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Pinto+PA%22">Pinto PA</searchLink>; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Zhang+Q%22">Zhang Q</searchLink>; Division of Cancer Treatment and Diagnosis: Biometric Research Program, National Cancer Institute, National Institutes of Health, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Shih+J%22">Shih J</searchLink>; Division of Cancer Treatment and Diagnosis: Biometric Research Program, National Cancer Institute, National Institutes of Health, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Salerno+KE%22">Salerno KE</searchLink>; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Citrin+DE%22">Citrin DE</searchLink>; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101677247%22">Advances in radiation oncology</searchLink> [Adv Radiat Oncol] 2022 Jul 15; Vol. 7 (6), pp. 101024. <i>Date of Electronic Publication: </i>2022 Jul 15 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101677247 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2452-1094 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224521094%22">24521094 </searchLink><i>NLM ISO Abbreviation: </i>Adv Radiat Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36420197 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.adro.2022.101024 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101024 Titles: – TitleFull: A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Patel KR – PersonEntity: Name: NameFull: Rowe LS – PersonEntity: Name: NameFull: Schott E – PersonEntity: Name: NameFull: Cooley-Zgela T – PersonEntity: Name: NameFull: Ning H – PersonEntity: Name: NameFull: Turkbey B – PersonEntity: Name: NameFull: Choyke P – PersonEntity: Name: NameFull: Lindenberg L – PersonEntity: Name: NameFull: Mena E – PersonEntity: Name: NameFull: Pinto PA – PersonEntity: Name: NameFull: Zhang Q – PersonEntity: Name: NameFull: Shih J – PersonEntity: Name: NameFull: Salerno KE – PersonEntity: Name: NameFull: Citrin DE IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 07 Text: 2022 Jul 15 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 2452-1094 Numbering: – Type: volume Value: 7 – Type: issue Value: 6 Titles: – TitleFull: Advances in radiation oncology Type: main |
| ResultId | 1 |